Real-world COPD trial examines triple-combination therapies
from MD Magazine
The world’s largest pragmatic clinical trial on chronic obstructive pulmonary disease (COPD), AIRWISE, is being undertaken by a trio of healthcare companies to study patients in a real-world setting. With a goal of studying which commonly prescribed therapies can reduce exacerbations in patients with COPD, a consequence of the condition that has long plagued these patients.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063